Unknown endogenous renal growth-regulatory target

The Unknown endogenous renal growth-regulatory target refers to a hypothesized or proprietary molecular site involved in the regulation of kidney tissue growth and repair. This target is primarily associated with the development of BB3 (also known as Angion), a small molecule hepatocyte growth factor (HGF) mimetic designed to treat acute kidney injury by promoting the survival and regeneration of renal proximal tubule cells. While the drug BB3 is often described as acting through HGF-like pathways, the specific 'endogenous renal growth-regulatory target' is frequently used in clinical literature to describe the functional site of action when the exact receptor-ligand stoichiometry or specific molecular identity is not fully characterized in a standard nomenclature. In the context of renal disease, this target is critical for initiating cellular repair mechanisms following ischemic or toxic insult. Modulating this target aims to reduce the progression of acute kidney injury to chronic kidney disease by accelerating the restoration of renal function.

Other names

Renal growth-regulatory targetEndogenous renal growth factor receptor

Agonism of a growth-regulatory pathway to stimulate renal cell repair and regeneration.